Admission Date:  [**2133-4-8**]     Discharge Date:  [**2133-4-29**]  Date of Birth:   [**2133-4-4**]     Sex:  F  Service:  Neonatology  HISTORY OF PRESENT ILLNESS:  Baby girl [**Known lastname 29469**], twin I, was a 36-week, 2795-gram [**Known lastname 43610**] product of a 30-year-old gravida 4, para 0 to 2 mother with serologies O positive, antibody negative, Rubella immune, rapid plasma reagin nonreactive, hepatitis B not detected, group B strep status negative.
Delivery was by cesarean section secondary to spontaneous rupture of this twin and breech positioning.
Baby girl [**Known lastname 29469**] was in the Newborn Nursery when she was noted to have a dusky episode associated with apnea for which she was admitted to the Neonatal Intensive Care Unit.
CARDIOVASCULAR ISSUES:  Baby girl [**Known lastname 29469**] has been cardiovascularly stable with the exception of bradycardias associated with feedings per above.
FLUIDS/ELECTROLYTES/NUTRITION ISSUES:  Baby girl [**Known lastname 29469**] has been maintained breast milk 20 and Enfamil 20 throughout her hospital course.
GASTROINTESTINAL ISSUES:  Baby girl [**Known lastname 29469**] was treated with phototherapy for hyperbilirubinemia.
She was treated with phototherapy for two days.
She received no transfusions during her admission, and her most recent hematocrit was 33.8 on [**2133-4-20**].
She was treated with ampicillin and gentamicin for 48 hours which was discontinued after the cultures were negative.
Medications at discharge:  Tri-Vi-[**Male First Name (un) **] 1 cc by mouth once per day and Desitin to diaper area as needed.
IMMUNIZATIONS RECOMMENDED:  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) born at less than 32 weeks gestation; (2) born between 32 and 35 weeks gestation with 2/3 of the following: plans for day care during respiratory syncytial virus season, with a smoker in the household, neuromuscular disease, airway abnormalities, or with school-age siblings; and/or (3) with chronic lung disease.
Influenza immunization should be considered annually in the Fall for preterm infants with chronic lung disease once they reach six months of age.
